63104. De Raeve LE, Claes A, Ruiter DJ, van Muijen GN, Roseeuw D, van Kempen LC.Distinct phenotypic changes between the superficial and deep component of giant congenitalmelanocytic naevi: a rationale for curettage. Br J Dermatol. 2006; 154(3): 485-92.105. Ely JF. Cirurgia Plástica. 2ª ed. Rio de Janeiro: Guanabara Koogan; 1980. p. 422-9.106. Gosain AK, Santoro TD, Larson DL, Gingrass RP. Giant congenital nevi: a 20-yearexperience and an algorithm for their management. Plast Reconstr Surg. 2001; 108: 622-36.107. Ozerdem OR, Wolfe AS, Marshall D. Use of Skin Substitutes in Pediatric Patients.J Craniofac Surg. 2003; 14(4): 517-20.108. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterizationof a model extracellular matrix that induces partial regeneration of adult mammalian skin.Proc Natl Acad Sci USA. 1989; 86(3): 933-7.109. Pereima ML, Erdmann AG. O uso de matriz de regeneração dérmica no tratamento donevus piloso gigante [trabalho de conclusão de curso]. Florianópolis: Universidade Federal deSanta Catarina, Curso de Medicina; 2005.110. Pereima MJL, Perdomo HAR. Estudo da utilização de matriz de regeneração dérmica emcrianças com seqüelas de queimaduras [trabalho de conclusão de curso]. Florianópolis:Universidade Federal de Santa Catarina, Curso de Medicina; 2003.111. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD. Cultured skin substitutescombined with Integra Artificial Skin to replace native skin autograft and allograft for theclosure of excised full-thickness burns. J Burn Care Rehabil. 1999; 20(6): 453-61.112. Jones I, Currie L, Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002;55: 185-93.113. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineeredskin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol. 1999; 135(10):1219-22.114. Falabella AF, Valencia IC, Eaglestein WH, Schachner LA. Tissue engineered skin(Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol.2000; 136(10): 1225-30.115. Prystowsky JH, Nowygrod R, Marboe CC, Benvenisty AL, Ascherman JA, Todd GJ.Artificial skin (Integra TM dermal regeneration template) for closure of lower extremitywounds. Vasc Endovascular Surg. 2000; 34(6): 557-67.116. Frame JD, Still J, Lakhel-LeCoadou A, Carstens MH, Lorenz C, Orlet H, et al. Use ofdermal regeneration template in contracture release procedures: a Multicenter evaluation.Plast Reconstr Surg. 2004; 113(5): 1330-8.117. Merz J, Schrand C, Mertens D, Foote C, Porter K, Regnold L. Wound care of thepediatric burn patient. AACN Clin Issues. 2003; 14 (4): 429-41.
64118. Clayton MC, Bishop JF. Perioperative and Postoperative Dressing Techniques forIntegra artificial Skin: Views from two medical centers. J Burn Care Rehabil. 1998; 19: 358-63.119. Sheridan RL, Hegarty M, Tompkins RG, Burke JF. Artificial skin used in the treatmentof full-thickness thrend injury. J Burn Care Rehabil. 1990; 11: 7-13.120. Molnar JA, DeFranzo AJ, Hadaegh A, Morykwas MJ, Shen P, Argenta LC. Accelerationof Integra incorporation in complex tissue defects with subatmospheric pressure. PlastReconstr Surg. 2004; 113(5): 1339-46.121. Heimbach DM, Luterman A, Burke J, Cram A, Hemdon D, Hunt J, et al. Artificialdermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988; 208: 313-20.122. Lourenz CH, Petracic A, Hohl HP, Wessel L, Woog KL. Early wound closure and earlyreconstruction: Experience with a dermal substitute in a child with 60 percent surface areaburn. Burns. 1997; 23(6): 505-8.123. Berger A, Tanzella U, Machens G, Liebau J. Der Einsatz von Integra bei primärenVerbrennungswunden und instabilen sekundären Narben. Chirurg. 2000; 71: 558-63.
- Page 1 and 2:
GUSTAVO KNOBLAUCH BORGES DE FIGUEIR
- Page 3 and 4:
de Figueiredo, Gustavo Knoblauch Bo
- Page 5 and 6:
ivAGRADECIMENTOSAos meus pais, Wand
- Page 8 and 9:
viiLISTA DE FIGURASFIGURA 1 - Desen
- Page 10:
ixLISTA DE ABREVIATURAS E SIGLASCo.
- Page 13 and 14:
2de associação com um quadro neur
- Page 15 and 16:
42. REVISÃO DA LITERATURA2.1) A Pe
- Page 17 and 18:
6Na derme papilar, o colágeno form
- Page 19 and 20:
82.3) As Lesões Relacionadas ao Si
- Page 21 and 22:
10Existem algumas características
- Page 23 and 24: 12transformação maligna desses tu
- Page 25 and 26: 142.5.5) ImportânciaA importância
- Page 27: 16monitoramento das lesões, acredi
- Page 30 and 31: 19tratada se torna hipopigmentada,
- Page 32 and 33: 21seqüelas - vários estudos têm
- Page 34 and 35: 23Figura 3: Matriz de regeneração
- Page 36 and 37: 25produtos têm ampliado o seu lequ
- Page 38 and 39: 273. OBJETIVOS3.1. Objetivo Geral:
- Page 40 and 41: 294) retração cicatricial (presen
- Page 42 and 43: 31Figura 8: Após 21 dias do implan
- Page 44 and 45: 33Figura 11: Pré-operatório. Face
- Page 46 and 47: 35Figura 16: Pós-operatório imedi
- Page 48 and 49: 37A reavaliação em nível ambulat
- Page 50 and 51: 395.2.3) Operação e Resultados:Co
- Page 52 and 53: 41enxertia e recebeu alta hospitala
- Page 54 and 55: 43Onze dias após a enxertia, quand
- Page 56 and 57: 45• Antecedentes pessoais: Respon
- Page 58 and 59: 47Figura 30: Região abdominal apó
- Page 60 and 61: 496. DISCUSSÃOO nevus melanocític
- Page 62 and 63: 51Ozerdem et al. 107 ressaltaram co
- Page 64 and 65: 53(na região medial da lesão), fo
- Page 66 and 67: 55nivelada e lisa (ou, no máximo,
- Page 68 and 69: 5715. Lorentzen M, Pers M, Brettvil
- Page 70 and 71: 5945. Pereima ML, Mattar CA, Novaes
- Page 72 and 73: 6175. Erickson CA. From the crest t
- Page 76 and 77: 65NORMAS ADOTADASEste trabalho foi
- Page 78 and 79: 67APÊNDICEPROTOCOLO DE COLETA DE D
- Page 80 and 81: 6912 MESESCOR DA PELE: ( ) Hipocora
Change language